Vanda Pharmaceuticals | VNDA - Action





Action Changement Date
Acadia Pharmaceuticals USD 31.57M 3.1M 2026-03
Agios Pharmaceuticals USD 35.09M 2.17M 2026-03
Akebia Therapeutics USD 13M 2.61M 2026-03
Alnylam Pharmaceuticals USD 200.15M 117.43M 2026-03
Anika Therapeutics USD 22.84M 4.05M 2026-03
Arrowhead Research USD -173.08M 173.08M 2024-12
AstraZeneca USD 6.57B 13M 2026-03
Bristol-Myers Squibb USD 2.76B 66M 2026-03
Eli Lilly USD 14.53B 785M 2026-03
Esperion Therapeutics USD 104.21M 915K 2026-03
Halozyme Therapeutics USD 155.47M 21.01M 2026-03
Heron Therapeutics USD 54.57M 2.33M 2022-12
Insmed USD 132.91M 841K 2026-03
J&J USD 14.58B 392M 2026-03
Lexicon Pharmaceuticals USD 276K 5K 2026-03
Ligand Pharmaceuticals USD 13.27M 4.14M 2026-03
Merck USD 6.48B 179M 2026-03
Moderna USD 146M 7M 2026-03
Novartis USD 6.29B 135M 2026-03
Pfizer USD 10.67B 13M 2026-03
PTC Therapeutics USD 75.57M 4.08M 2026-03
Puma Biotechnology USD 9.48M 885K 2025-09
Sanofi EUR 22.69B 1.81B 2025-12
Takeda JPY 1.41T 107.71B 2025-12
Teva Pharmaceutical Industries USD 3.18B 144M 2025-12
Ultragenyx Pharmaceutical USD 55M 3M 2026-03
Vanda Pharmaceuticals USD 1.85M 190K 2025-12
Veracyte USD 21.42M 870K 2026-03